Your account is not claimed yet. You can sign up with ORCID to claim your account.

Teh-Ia Huo (T-I Huo)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 49

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Cancers

Hepatology (Baltimore, Md.)

Journal of gastroenterology and hepatology

This page only lists publications with an associated author ORCID identifier.

Publications

Wei-Yu Kao, Elise Chia-Hui Tan, Hsin-Lun Lee, Yi-Hsiang Huang, Teh-Ia Huo, Chun-Chao Chang, Jeng-Fong Chiou, Ming-Chih Hou, Jaw-Ching Wu, Chien-Wei Su
Entecavir versus tenofovir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative hepatectomy. Alimentary pharmacology & therapeutics (2023)
Jia-I Liao, Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, Yi-Hsiang Huang, Chien-Wei Su, Ming-Chih Hou, Teh-Ia Huo
Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI Grade. Cancers 15 (3) (2023)
Jia-I Liao, Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, Yi-Hsiang Huang, Chien-Wei Su, Ming-Chih Hou, Teh-Ia Huo
Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI Grade. Cancers 15 (3) (2023)
Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, Yi-Hsiang Huang, Jia-I Liao, Chien-Wei Su, Ming-Chih Hou, Teh-Ia Huo
Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Cancers 15 (7) (2023)
Teh-Ia Huo, Shu-Yein Ho, Jia-I Liao
Predicting post-resection early recurrence of hepatocellular carcinoma: Defining the role of microvascular invasion. Liver international : official journal of the International Association for the Study of the Liver (2023)
Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, Yi-Hsiang Huang, Jia-I Liao, Chien-Wei Su, Ming-Chih Hou, Teh-Ia Huo
A New Tumor Burden Score and Albumin-Bilirubin Grade-Based Prognostic Model for Hepatocellular Carcinoma. Cancers 14 (3) (2022)
Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, Yi-Hsiang Huang, Jia-I Liao, Chien-Wei Su, Ming-Chih Hou, Teh-Ia Huo
Radiofrequency Ablation versus Transarterial Chemoembolization for Hepatocellular Carcinoma within Milan Criteria: Prognostic Role of Tumor Burden Score. Cancers 14 (17) (2022)
Teh-Ia Huo, Jia-I Liao, Shu-Yein Ho
3-Mercaptopyruvate sulfurtransferase in hepatocellular carcinoma: Is it an authentic clinical prognostic predictor? Liver international : official journal of the International Association for the Study of the Liver 42 (6) (2022)
Teh-Ia Huo, Jia-I Liao, Shu-Yein Ho
Developing real-world prognostic models for patients with advanced hepatocellular carcinoma: CRAFITY, mALF and beyond. Hepatology international (2022)
Teh-Ia Huo, Shu-Yein Ho, Jia-I Liao
Look for new biomarkers in the management of hepatocellular carcinoma: What the hepatologists may need to know. Liver international : official journal of the International Association for the Study of the Liver (2022)
Teh-Ia Huo, Shu-Yein Ho, Po-Hong Liu
Changing epidemiological features of hepatocellular carcinoma: Taiwan's position. Liver international : official journal of the International Association for the Study of the Liver 42 (12) (2022)
Teh-Ia Huo, Shu-Yein Ho, Jia-I Liao
Improving the accuracy of outcome prediction for hepatocellular carcinoma: Asia strategies. Liver international : official journal of the International Association for the Study of the Liver 42 (3) (2022)
Chih-Chieh Ko, Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, Cheng-Yuan Hsia, Yi-Hsiang Huang, Chien-Wei Su, Hao-Jan Lei, Rheun-Chuan Lee, Ming-Chih Hou, Teh-Ia Huo
Dual hepatitis B and C-associated hepatocellular carcinoma: clinical characteristics, outcome, and prognostic role of albumin-bilirubin grade. International journal of clinical oncology 27 (4) (2022)
Shiuan-Chen Lin, Chun Ma, Kao-Jung Chang, Han-Ping Cheong, Ming-Cheng Lee, Yuan-Tzu Lan, Chien-Ying Wang, Shih-Hwa Chiou, Teh-Ia Huo, Tsui-Kang Hsu, Ping-Hsing Tsai, Yi-Ping Yang
The Post-Translational Modification Networking in WNK-Centric Hypertension Regulation and Electrolyte Homeostasis. Biomedicines 10 (9) (2022)
Teh-Ia Huo, Shu-Yein Ho, Po-Hong Liu
Changing patterns of etiology and management of hepatocellular carcinoma: need for global reappraisal. Journal of gastroenterology 56 (4) (2021)
Teh-Ia Huo, Shu-Yein Ho, Ping-Hsing Tsai
Post hepatitis B-eliminated hepatocellular carcinoma: New challenges. Liver international : official journal of the International Association for the Study of the Liver 41 (5) (2021)
Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, Chih-Chieh Ko, Yi-Hsiang Huang, Chien-Wei Su, Rheun-Chuan Lee, Ping-Hsing Tsai, Ming-Chih Hou, Teh-Ia Huo
Tumor burden score as a new prognostic marker for patients with hepatocellular carcinoma undergoing transarterial chemoembolization. Journal of gastroenterology and hepatology 36 (11) (2021)
Teh-Ia Huo, S-Y Ho, J-I Liao
Improved patient survival in hepatitis C virus-related hepatocellular carcinoma: Do direct-acting antivirals play a role? Journal of gastroenterology and hepatology (2021)
Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, Chih-Chieh Ko, Yi-Hsiang Huang, Chien-Wei Su, Cheng-Yuan Hsia, Ping-Hsing Tsai, Shih-Jie Chou, Rheun-Chuan Lee, Ming-Chih Hou, Teh-Ia Huo
Easy albumin-bilirubin score as a new prognostic predictor in hepatocellular carcinoma. Hepatology research : the official journal of the Japan Society of Hepatology 51 (11) (2021)
Teh-Ia Huo, Shu-Yein Ho, Chih-Chieh Ko
Nomogram for surgical hepatocellular carcinoma: What have we missed? Liver international : official journal of the International Association for the Study of the Liver (2021)
Teh-Ia Huo, Po-Hong Liu, Chia-Yang Hsu
Letter to the Editor: Using Circulating Biomarkers to Stage HCC: Pitfalls and Limitations. Hepatology (Baltimore, Md.) 73 (6) (2021)
Shu-Yein Ho, Chia-Yang Hsu, Po-Hong Liu, Rheun-Chuan Lee, Chih-Chieh Ko, Yi-Hsiang Huang, Chien-Wei Su, Ming-Chih Hou, Teh-Ia Huo
Albumin-Bilirubin (ALBI) Grade-Based Nomogram for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Digestive diseases and sciences 66 (5) (2020)
Teh-Ia Huo, Shu-Yein Ho, Po-Hong Liu
Predicting microvascular invasion in HCC with ctDNA: What are the pitfalls? Liver international : official journal of the International Association for the Study of the Liver 41 (5) (2020)
Shu-Yein Ho, Lei-Chi Wang, Chia-Yang Hsu, Po-Hong Liu, Cheng-Yuan Hsia, Yi-Hsiang Huang, Teh-Ia Huo
Metavir Fibrosis Stage in Hepatitis C-Related Hepatocellular Carcinoma and Association with Noninvasive Liver Reserve Models. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 24 (8) (2020)
Teh-Ia Huo, Po-Hong Liu, Chia-Yang Hsu
Staging and Restaging for Hepatocellular Carcinoma: Solution of Confusion? Hepatology (Baltimore, Md.) 69 (1) (2020)
Teh-Ia Huo, Po-Hong Liu, Chia-Yang Hsu
Tumour burden score for hepatocellular carcinoma: Is it an authentic prognostic marker? The British journal of surgery 107 (12) (2020)
Teh-Ia Huo, Po-Hong Liu, Shu-Yein Ho
Are inflammation-based models feasible tools in predicting the outcome of patients with hepatocellular carcinoma? Liver international : official journal of the International Association for the Study of the Liver 40 (6) (2020)
Teh-Ia Huo, S-Y Ho, P-H Liu
Is computed tomography-enhanced clinical significant portal hypertension surrogate an authentic prognostic predictor for surgical hepatocellular carcinoma? Journal of gastroenterology and hepatology 35 (12) (2020)
Teh-Ia Huo, Shu-Yein Ho, Po-Hong Liu
Changing faces of hepatocellular carcinoma: East vs West. Liver international : official journal of the International Association for the Study of the Liver 41 (6) (2020)
Teh-Ia Huo, Po-Hong Liu, Shu-Yein Ho
Treating Small Hepatocellular Carcinoma: Stereotactic Body Radiation Therapy Versus Radiofrequency Ablation. Journal of gastroenterology and hepatology 35 (11) (2020)
Po-Hong Liu, Chia-Yang Hsu, Chien-Wei Su, Yi-Hsiang Huang, Ming-Chih Hou, Nicole E Rich, Naoto Fujiwara, Yujin Hoshida, Amit G Singal, Teh-Ia Huo
Thrombocytosis is associated with worse survival in patients with hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver 40 (10) (2020)
Pei-Chang Lee, Yi-You Chiou, Nai-Chi Chiu, Ping-Hsien Chen, Chien-An Liu, Wei-Yu Kao, Teh-Ia Huo, Yi-Hsiang Huang, Ming-Chih Hou, Han-Chieh Lin, Jaw-Ching Wu, Chien-Wei Su
Liver stiffness measured by acoustic radiation force impulse elastography predicted prognoses of hepatocellular carcinoma after radiofrequency ablation. Scientific reports 10 (1) (2020)
Shu-Yein Ho, Mei-Hsia Yuan, Chu-Chieh Chen, Po-Hong Liu, Chia-Yang Hsu, Yi-Hsiang Huang, Hao-Jan Lei, Rheun-Chuan Lee, Teh-Ia Huo
Differential Survival Impact of Diabetes Mellitus on Hepatocellular Carcinoma: Role of Staging Determinants. Digestive diseases and sciences 65 (11) (2020)
Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, Cheng-Yuan Hsia, Yi-Hsiang Huang, Chien-Wei Su, Hao-Jan Lei, Rheun-Chuan Lee, Ming-Chih Hou, Teh-Ia Huo
A New Prognostic Model Based on Albumin-Bilirubin Grade for Hepatocellular Carcinoma Beyond the Milan Criteria. Digestive diseases and sciences 65 (2) (2019)
Wei-Yu Kao, Chien-Wei Su, Elise Chia-Hui Tan, Pei-Chang Lee, Ping-Hsien Chen, Jui-Hsiang Tang, Yi-Hsiang Huang, Teh-Ia Huo, Chun-Chao Chang, Ming-Chih Hou, Han-Chieh Lin, Jaw-Ching Wu
Proton Pump Inhibitors and Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B or C. Hepatology (Baltimore, Md.) 69 (3) (2019)
I-Cheng Lee, Ya-Wen Hung, Chien-An Liu, Rheun-Chuan Lee, Chien-Wei Su, Teh-Ia Huo, Chung-Pin Li, Yee Chao, Han-Chieh Lin, Ming-Chih Hou, Yi-Hsiang Huang
A new ALBI-based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver 39 (9) (2019)
Shu-Yein Ho, Chia-Yang Hsu, Po-Hong Liu, Cheng-Yuan Hsia, Hao-Jan Lei, Yi-Hsiang Huang, Chih-Chieh Ko, Chien-Wei Su, Rheun-Chuan Lee, Ming-Chih Hou, Teh-Ia Huo
Albumin-bilirubin grade-based nomogram of the BCLC system for personalized prognostic prediction in hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver 40 (1) (2019)
Teh-Ia Huo, Shu-Yein Ho
Evolution of hepatocellular carcinoma: non-B, non-C and beyond. Journal of gastroenterology 55 (1) (2019)
Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, Cheng-Yuan Hsia, Chien-Wei Su, Yi-Jhen He, Yun-Hsuan Lee, Yi-Hsiang Huang, Ming-Chih Hou, Teh-Ia Huo
Current noninvasive liver reserve models do not predict histological fibrosis severity in hepatocellular carcinoma. Scientific reports 8 (1) (2018)
Chia-Yang Hsu, Po-Hong Liu, Shu-Yein Ho, Cheng-Yuan Hsia, Praneeth Kudaravalli, Yun-Hsuan Lee, Yi-You Chiou, Ya-Ju Tsai, Yi-Hsiang Huang, Teh-Ia Huo
Using nomogram of the Barcelona Clinic Liver Cancer system for treatment selection in patients with stage C hepatocellular carcinoma. BMC cancer 18 (1) (2018)
Yun-Cheng Hsieh, Kuei-Chuan Lee, Ying-Wen Wang, Ying-Ying Yang, Ming-Chih Hou, Teh-Ia Huo, Han-Chieh Lin
Correlation and prognostic accuracy between noninvasive liver fibrosismarkers and portal pressure in cirrhosis: Role of ALBI score. PloS one 13 (12) (2018)
Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, Yi-You Chiou, Chien-Wei Su, Yun-Hsuan Lee, Yi-Hsiang Huang, Fa-Yauh Lee, Ming-Chih Hou, Teh-Ia Huo
Prognostic Performance of Ten Liver Function Models in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation. Scientific reports 8 (1) (2018)
Teh-Ia Huo, Chia-Yang Hsu, Po-Hong Liu
Magic mirror on the wall: Which is the best biomarker for hepatocellular carcinoma? Hepatology (Baltimore, Md.) 67 (6) (2018)
Chia-Yang Hsu, Po-Hong Liu, Shu-Yein Ho, Yi-Hsiang Huang, Yun-Hsuan Lee, Rheun-Chuan Lee, Teddy S Nagaria, Ming-Chih Hou, Teh-Ia Huo
Metastasis in patients with hepatocellular carcinoma: Prevalence, determinants, prognostic impact and ability to improve the Barcelona Clinic Liver Cancer system. Liver international : official journal of the International Association for the Study of the Liver 38 (10) (2018)
Yi-Ying Lin, Yueh Chien, Jen-Hua Chuang, Chia-Ching Chang, Yi-Ping Yang, Ying-Hsiu Lai, Wen-Liang Lo, Ke-Hung Chien, Teh-Ia Huo, Chien-Ying Wang
Development of a Graphene Oxide-Incorporated Polydimethylsiloxane Membrane with Hexagonal Micropillars. International journal of molecular sciences 19 (9) (2018)
Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, Cheng-Yuan Hsia, Chien-Wei Su, Yun-Hsuan Lee, Yi-Hsiang Huang, Fa-Yauh Lee, Ming-Chih Hou, Teh-Ia Huo
Comparison of twelve liver functional reserve models for outcome prediction in patients with hepatocellular carcinoma undergoing surgical resection. Scientific reports 8 (1) (2018)
Chia-Yang Hsu, Po-Hong Liu, Shu-Yein Ho, Yi-Hsiang Huang, Yun-Hsuan Lee, Yi-You Chiou, Ting-Hui Hsieh, Tom Fang, Ya-Ju Tsai, Ming-Chih Hou, Teh-Ia Huo
Impact of tumor burden on prognostic prediction for patients with terminal stage hepatocellular carcinoma: A nomogram study. PloS one 12 (11) (2017)
Pei-Chang Lee, Yi-Tzen Chen, Yee Chao, Teh-Ia Huo, Chung-Pin Li, Chien-Wei Su, Mei-Hsuan Lee, Ming-Chih Hou, Fa-Yauh Lee, Han-Chieh Lin, Yi-Hsiang Huang
Validation of the albumin-bilirubin grade-based integrated model as a predictor for sorafenib-failed hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver 38 (2) (2017)
Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, Cheng-Yuan Hsia, Yun-Hsuan Lee, Rheun-Chuan Lee, Yi-Hsiang Huang, Fa-Yauh Lee, Ming-Chih Hou, Ya-Ju Tsai, Teh-Ia Huo
Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization. PloS one 12 (7) (2017)

Teh-Ia Huo.css-eqlu8i{font-size:small;padding-left:4px;} (T-I Huo)

Publication Activity (10 Years)

Top Topics

Top Venues

Teh-Ia Huo (T-I Huo)